Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increasing complexity of the dystrophin-associated protein complex.

Literature DB >> 8078878

Increasing complexity of the dystrophin-associated protein complex.

J M Tinsley¹, D J Blake, R A Zuellig, K E Davies.

Abstract

Duchenne muscular dystrophy is a severe X chromosome-linked, muscle-wasting disease caused by lack of the protein dystrophin. The exact function of dystrophin remains to be determined. However, analysis of its interaction with a large oligomeric protein complex at the sarcolemma and the identification of a structurally related protein, utrophin, is leading to the characterization of candidate genes for other neuromuscular disorders.

Entities: Disease Gene

Mesh：

Substances：

Year: 1994 PMID： 8078878 PMCID： PMC44595 DOI： 10.1073/pnas.91.18.8307

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

57 in total

1. Abnormal localization of laminin subunits in muscular dystrophies.

Authors: Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal: J Neurol Sci Date: 1993-10 Impact factor: 3.181

2. Expression of dystrophin-associated protein 35DAG (A4) and 50DAG (A2) is confined to striated muscles.

Authors: H Yamamoto; Y Mizuno; K Hayashi; I Nonaka; M Yoshida; E Ozawa
Journal: J Biochem Date: 1994-01 Impact factor: 3.387

3. Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle.

Authors: A Clerk; G E Morris; V Dubowitz; K E Davies; C A Sewry
Journal: Histochem J Date: 1993-08

4. Heterogeneity of dystrophin-associated proteins.

Authors: H Yamamoto; Y Hagiwara; Y Mizuno; M Yoshida; E Ozawa
Journal: J Biochem Date: 1993-07 Impact factor: 3.387

5. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors: K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal: Am J Hum Genet Date: 1993-08 Impact factor: 11.025

6. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.

Authors: K Matsumura; I Nonaka; K P Campbell
Journal: Lancet Date: 1993-02-27 Impact factor: 79.321

7. The emerging family of dystrophin-related proteins.

Authors: D J Blake; J M Tinsley; K E Davies
Journal: Trends Cell Biol Date: 1994-01 Impact factor: 20.808

8. Primary structure of dystrophin-related protein.

Authors: J M Tinsley; D J Blake; A Roche; U Fairbrother; J Riss; B C Byth; A E Knight; J Kendrick-Jones; G K Suthers; D R Love
Journal: Nature Date: 1992-12-10 Impact factor: 49.962

9. The utrophin and dystrophin genes share similarities in genomic structure.

Authors: M Pearce; D J Blake; J M Tinsley; B C Byth; L Campbell; A P Monaco; K E Davies
Journal: Hum Mol Genet Date: 1993-11 Impact factor: 6.150

10. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors: J M Ervasti; K P Campbell
Journal: J Cell Biol Date: 1993-08 Impact factor: 10.539

36 in total

1. Muscular dystrophy: from gene to patient.

Authors: J C Hopkins; B L Bia; J G Crilley; E A Boehm; A E Sang; J M Tinsley; L M King; G K Radda; K E Davies; K Clarke
Journal: MAGMA Date: 2000-11 Impact factor: 2.310

2. AChR phosphorylation and aggregation induced by an agrin fragment that lacks the binding domain for alpha-dystroglycan.

Authors: T Meier; M Gesemann; V Cavalli; M A Ruegg; B G Wallace
Journal: EMBO J Date: 1996-06-03 Impact factor: 11.598

3. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors: P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal: J Clin Invest Date: 1997-10-01 Impact factor: 14.808

Review 4. The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors: S J Winder
Journal: J Muscle Res Cell Motil Date: 1997-12 Impact factor: 2.698

5. beta-dystrobrevin, a member of the dystrophin-related protein family.

Authors: D J Blake; R Nawrotzki; N Y Loh; D C Górecki; K E Davies
Journal: Proc Natl Acad Sci U S A Date: 1998-01-06 Impact factor: 11.205

6. Neural agrin induces ectopic postsynaptic specializations in innervated muscle fibers.

Authors: T Meier; D M Hauser; M Chiquet; L Landmann; M A Ruegg; H R Brenner
Journal: J Neurosci Date: 1997-09-01 Impact factor: 6.167

7. Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury.

Authors: Su Xu; Stephen J P Pratt; Espen E Spangenburg; Richard M Lovering
Journal: J Appl Physiol (1985) Date: 2012-06-28

8. Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors.

Authors: Yuko Iwata; Yuki Katanosaka; Takashi Hisamitsu; Shigeo Wakabayashi
Journal: Am J Pathol Date: 2007-09-06 Impact factor: 4.307

9. Molecular and functional analysis of the utrophin promoter.

Authors: C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal: Nucleic Acids Res Date: 1996-05-01 Impact factor: 16.971

10. Regulation of the interaction of nicotinic acetylcholine receptors with the cytoskeleton by agrin-activated protein tyrosine kinase.

Authors: B G Wallace
Journal: J Cell Biol Date: 1995-03 Impact factor: 10.539